Drug Science

Drug Science is the UK's leading independent scientific body on drugs - guiding evidence-based drug policy and drug research. Please donate to support our work.

[Drug Science @Drug_Science]

Why do so few mental health drugs actually work? 🧐 🧠

In a special new opinion piece, @profdavidnutt presents a radical take on what the pharma industry gets wrong in its search for new treatments.

Check it out now 👇
https://t.co/ivbA2nOerl

[Drug Science @Drug_Science]

The UK needs to learn from this 🇬🇧👂🇨🇿

An expert psychiatrist breaks down the Czech Republic's groundbreaking psilocybin therapy regulations, covering who can get it, what for, and what the NHS desparately needs to learn.

Check it out 👇
https://t.co/eeow9FxJS5

[Drug Science @Drug_Science]

Francis Crick is famous for discovering the double helix, but fewer know about his career in consciousness research. This week, Prof Matthew Cobb joins us on the podcast for a warm and meandering chat about this remarkable life and career.

Listen now at https://t.co/ebGeYqiEqt

[Drug Science @Drug_Science]

Don't forget to book your tickets for this one! A fascinating look at the truths and misconceptions behind 5MEO from one of the world's experts.

🎟 ️https://t.co/C71QsTRyE7

Free/discounted tickets available for DS community members - just email [email protected] ♥️

[Drug Science @Drug_Science]

Ketamine treats depression faster than any other drug, and Norway is the first country to offer it to its citizens for free.

In this piece, we break down the history of ketamine therapy, how it works, and what makes Norway special:

https://t.co/Ru2IxCkjNK

[The Naked Scientists @NakedScientists]

This week, we focus on #depression, following #MentalHealthAwarenessWeek. This episode features Trevor Robbins (@CamNeuro), Munro Stewart (@rcgp), Jackie Rogers (@BACP), and David Nutt (@imperialcollege)
https://t.co/rJm9bTRNIQ

[Drug Science @Drug_Science]

👁️ Want to learn more about 5-MEO-DMT? Join Dr Alan Davis and The Psychedelic Society for an in-depth exploration of this remarkable drug. 7-8.30 pm, Sun 31/05

💌 Free and discounted tickets available for all Drug Science community members!

🎟️🔗 https://t.co/ZKWEmmxVkl

[Drug Science @Drug_Science]

New outdoor smoking bans would treat vapes and heated tobacco products (HTPs) equally to cigarettes.

While we agree with making smoking harder and less visible, grouping safer alternatives with cigarettes is the wrong move.

Our response 👉 https://t.co/N3ZuNU5t5W

[Drug Science @Drug_Science]

Humans have been using alcohol for millennia. Is it time to update the recipe?

This week on the podcast, David Orren joins Prof Jo Neill to discuss alcohol in society, the story of Gaba Labs and the challenges of taking on the alcohol industry.

Out now on all platforms 🎧

[Drug Science @Drug_Science]

Cocaethylene forms in the body when cocaine and alcohol are consumed together, and has its own unique effects distinct from those of either drug.

New research from our journal looks at the connection between the molecule and cases of suicide.

Read now: https://t.co/GW6XOLMuTw

[Drug Science @Drug_Science]

Until 2004, personal ideology predicted a person's views on cannabis better than whether they identified as Democrat or Republican.

Now, cannabis attitudes are about ingroup v outgroup more than personal opinion.

Read the full article 🔗

https://t.co/JXrqxyCnxV

[Drug Science @Drug_Science]

We want new drug regulations to be informed by the data, but as medical cannabis advances across Europe, how do we make sure this actually happens?

Drug Science's Dr Anne Katrin Schlag is leading a panel to discuss at Cannabis Europa London. Tickets at: https://t.co/RknLgbqsKh

[Drug Science @Drug_Science]

Want to practise PAT in New Zealand?

This June, TheraPsil are launching their New Zealand-focused online training program , combining general training in psilocybin with NZ- and Māori-specific information and guidance.

⏬️Learn more and enrol now ⏬️
https://t.co/9YhRiLzCRW

[Drug Science @Drug_Science]

Have you bought your tickets yet to #ICPR 2026? Drug Science Community Members can receive 10% off - email [email protected] for your unique discount code!

See you in Haarlem from June 4-6 ✨

https://t.co/H9p69idu3U

[Drug Science @Drug_Science]

We're incredibly proud to announce Returning To Wholeness: a four-day psilocybin retreat for people living with or beyond cancer.

🗓️ 24–27 August 2026

📍De Hoorneboeg, Netherlands.

🌼 Free of charge to those who need it.

Learn more and apply at: https://t.co/wPAzGwqL7b

[Drug Science @Drug_Science]

Healthcare professional interested in working with psychedelics?

PsyEdu's excellent part-time Professional Certificate in Psychedelic Practice programme is running again in 26/27.

Sign up for the online open evening on 13th May to learn more
🔗⬇️

https://t.co/ZHcdYH3BXA

[Drug Science @Drug_Science]

Trump's executive order is designed to accelerate late-stage research into psychedelic therapies. In our latest blog post, we break down what this means, who's affected, and why ibogaine is getting so much attention.

Check out the full article now 👇

https://t.co/2kOdyLm6eV

[Drug Science @Drug_Science]

Want to keep up with what we're publishing in 2026? Subscribe to our email newsletter at https://t.co/Isu3omaokU to get all our latest publications directly in your inbox.

[Drug Science @Drug_Science]

Happy 4/20!

The last year has seen some big developments in the cannabis space, and we've been keeping track. Here are our favourite papers and blog posts we've published since this time in 2025...

[Drug Science @Drug_Science]

4. Cannabis helps with Ehlers-Danlos symptoms

Looking at EDS sufferers in Project T21, we showed that cannabis:

- Reduced pain severity and interference in daily life
- Improved mood and depression
- Improved quality of life
- Reduced opioid use

https://t.co/1FqGtm9SLc